JNJ
32
6
CHRW
44
2
SIG
70
-2
VRTX
62
4
GM
75
-2
F
54
2
URBN
52
-3
MU
50
-4
LOW
53
-2
KLAC
58
-5
PGR
74
4
WDC
55
-2
REGN
62
3
CCI
33
3
SE
50
-2
FTI
81
-3
GPS
47
-3
BF.B
50
-3
NOV
48
3
MET
43
6
JNJ
32
6
CHRW
44
2
SIG
70
-2
VRTX
62
4
GM
75
-2
F
54
2
URBN
52
-3
MU
50
-4
LOW
53
-2
KLAC
58
-5
PGR
74
4
WDC
55
-2
REGN
62
3
CCI
33
3
SE
50
-2
FTI
81
-3
GPS
47
-3
BF.B
50
-3
NOV
48
3
MET
43
6
Financhill
Back

Portage Biotech 10K Form

Sell
32

PRTG
Portage Biotech

Last Price:
0.26
Seasonality Move:
29.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRTG News And Ratings

See the #1 stock for the next 7 days that we like better than PRTG

PRTG Financial Statistics

Sales & Book Value

Annual Sales: $6.26K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.62
Price / Book: 0.14

Profitability

EPS (TTM): -8.34000
Net Income (TTM): $-144.9M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Portage Biotech Earnings Forecast

Key Portage Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for PRTG have been equal to 10,079.87% of Gross Profit Margin.
  • The Interest Expense is -0.01% of Operating Income.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Portage Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRTG
Website: portagebiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRTG Technical Analysis vs Fundamental Analysis

Sell
32
Portage Biotech (PRTG) is a Sell

Is Portage Biotech a Buy or a Sell?

  • Portage Biotech stock is rated a Sell
    The current Portage Biotech [PRTG] share price is $0.23. The Score for PRTG is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.